The BD SurePath™ test is:
- The only Pap test with an FDA-approved claim of a 64.4% increase in HSIL+ detection.
- The only Pap test with an FDA-approved claim to significantly reduce Unsatisfactory samples.
- The only Pap test where 100% of the collected sample is transferred to the vial for processing in the lab.
- Compatible with BD FocalPoint™ Imaging System technology for even greater scrutiny of cervical slides to reduce False Negatives.
- FDA-approved for out-of-vial CT/GC testing using the BD ProbeTec™ CT/GC Qx Amplified DNA Assays.
CellSolutions develops high quality liquid based preparation and evaluation systems for cytology applications.
Pending FDA-PMA approval, our primary area of focus will be women’s health, including cervical cancer screening, pre-cancer detection and evaluation of infectious disease. Currently, our products are suitable for a broad range of non-Gyn applications including urine and fine needle aspirations.
Cell Solutions BestPrep™ http://www.cellsols.com/